Christopher J. Passero

Christopher Passero practices at Dci Renal Services of Pittsburgh in Pittsburgh, Pennsylvania.

Christopher Passero's NPI, 1881891406, was assigned on June 28, 2007. Christopher Passero graduated from Warren Alpert Medical School of Brown University in 2002. Christopher Passero holds Pennsylvania license MD431441.

Christopher Passero's primary practice is Dci Renal Services of Pittsburgh, at 2 Hot Metal St, Pittsburgh, PA 15203 in Allegheny County. The practice phone is (412) 647-3700.

Christopher Passero's primary practice is Dci Renal Services of Pittsburgh in Pittsburgh, Pennsylvania. Christopher Passero is also affiliated with UPMC Presbyterian. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Christopher Passero to 4 more hospitals, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Passero practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Christopher Passero's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Christopher Passero is licensed in Pennsylvania.

CMS data shows 493 Medicare services from Christopher Passero across 7 procedure codes in 2024, for 240 Medicare patients. Medicare paid $36,452 for them.

CMS counts 240 Medicare patients who saw Christopher Passero in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 3.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christopher Passero's median patient age at 73, with 42% women.

In 2024, Christopher Passero wrote 898 Medicare Part D claims for 158 patients. 89% of them were for generic drugs. CMS names the drug for 750 of them, across 24 drugs with 11 or more claims each, at $54,892 in total drug cost. In 2023, CMS named 676 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Christopher Passero for performance year 2024, reported as part of a group. Christopher Passero accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christopher Passero as offering telehealth.

Dmand AI links 7 papers to Christopher Passero, published from 2010 to 2024. 2011 was the busiest year, with 3. The most frequent topics are Epithelial Sodium Channels and Cells, Cultured. Christopher Passero has published most often in Am J Physiol Renal Physiol. Christopher Passero's most frequent co-authors are Ala Abudayyeh, MD, Abinet M. Aklilu, MD and Anip Bansal, MD.

CMS Open Payments shows 1 general payment to Christopher Passero from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Relypsa, Inc. paid the most, $59.

Christopher Passero graduated from Warren Alpert Medical School of Brown University in 2002.